The Mood, Anxiety and Impulsivity Disorders Program at the Douglas Institute provides care to people aged 18 to 65 years with a mood disorder such as Bipolar disorders or Depressive and suicide disorders.

The Depressive and Suicide Disorders Program is a superspecialized (third-line) service for youth and adults who suffer from refractory and/or recurrent major depressive disorder with or without the presence of suicidal behaviour. The program offers cutting-edge treatment for clients and provides support to families to help them interact with the person in difficulty.

The Anxiety Disorders Clinic is a superspecialized (third-line) consultation, assessment and treatment service for people between the ages of 18 and 65 who suffer from one or multiple anxiety disorders.

People are referred to the Outpatient Clinic by the “guichet d’accès” of their CLSC or by other services at the Douglas Institute.

The Intensive Intervention Program provides diagnostic and super specialized services in mental health to youth aged 13 to 17 years who do not adequately respond to treatment.

Naguib Mechawar identifies the neurochemical and neuroanatomical properties of major depression and suicidal behaviors in the brain.

Hani Iskandar has been involved in clinical research projects in the fields of schizophrenia, mood disorders and pharmacology.  

Brigitte L. Kieffer, PhD, is the new Scientific Director of the Douglas Institute Research Centre

Eduardo Chachamovich’s work focuses mainly on social and clinical determinants of mental health in Aboriginal populations.

Researchers examining the “Mood, Anxiety, and Impulsivity-related Disorders” theme are aiming to identify the genetic , psychological, neurobiological and environmental causes of most mood disorders and testing the most effective treatments. Their main focus is on: Depression Bipolar disorder Personality disorders Post-traumatic stress disorder Eating disorders Substance dependence, e.g. drug or alcohol Suicide Identifying risk factors and responding ef...